Risankizumab Is Effective for The Management of Crohn’s Disease of the PouchMaia Kayal, Edward L. Barnes, Chelsea Anderson et al.|Inflammatory Bowel Diseases|2024Cited by 8
Dietary Patterns Are Not Associated With Disease Activity Among Patients With Inflammatory Conditions of the Pouch in a Prospective CohortEdward L. Barnes, Hans Herfarth, Poonam Beniwal‐Patel et al.|Crohn s & Colitis 360|2023Cited by 4
A Prospective Comparison of Ustekinumab and Antitumor Necrosis Factor α Therapy in the Treatment of Crohn's-Like Disease of the PouchEdward L. Barnes, Maia Kayal, Laura E. Raffals et al.|The American Journal of Gastroenterology|2025Cited by 2
S1120 Vedolizumab Is Effective for the Treatment of Chronic Inflammatory Conditions of the Pouch in a Prospective Multicenter StudyEdward L. Barnes, Hans Herfarth, Laura H. Raffals et al.|The American Journal of Gastroenterology|2023Cited by 1
125: USTEKINUMAB IS MORE EFFECTIVE THAN ANTI-TNF THERAPY IN CROHN’S-LIKE DISEASE OF THE POUCH: A PROSPECTIVE STUDYEdward L. Barnes, Maia Kayal, Laura H. Raffals et al.|Gastroenterology|2025Cited by 0